Recombinant Human XAGE1A Protein，His

XAGE1A is a member of the XAGE (X antigen gene) family and has garnered attention due to its role in cancer immunology. It is primarily expressed in various tumors, including melanoma and other malignancies, while being largely absent in normal tissues, making it a promising target for cancer immunotherapy. XAGE1A is classified as a cancer-testis (CT) antigen, which typically elicits immune responses in individuals with tumor presence but is not expressed in adult somatic tissues outside of germ cells. This unique expression pattern highlights its potential as a biomarker for tumor detection and as a target for vaccine development. Recent studies have focused on characterizing the recombinant protein of XAGE1A to explore its immunogenic properties, with the goal of enhancing T-cell responses in cancer patients. By using techniques such as recombinant DNA technology and protein expression in suitable systems, researchers aim to produce a functional form of XAGE1A that can be used in clinical applications. The understanding of its structure, expression, and interaction with the immune system is critical for developing novel immunotherapeutic strategies. Overall, the research on XAGE1A recombinant protein continues to be a promising area in the field of cancer biology, providing insights into potential therapeutic interventions aimed at harnessing the body's immune system to combat cancer.